Cedric Ververken is the founder of Confo Therapeutics. Confo Therapeutics has raised $106M in total funding. Latest round: Series B. Based in Ghent, Belgium.
Cedric Ververken is the Chief Executive Officer and Director of Confo Therapeutics, a clinical-stage biotech company founded in 2015. He leads the company's efforts to advance novel GPCR-modulating therapies and has overseen its progression from Series A to Series B financing.
Full founder directory · Investor directory · Company funding database · Fundraising library